The global dermatology lasers market size was USD 3.23 billion in 2023, calculated at USD 3.51 billion in 2024 and is projected to surpass around USD 7.23 billion by 2034, expanding at a CAGR of 7.5% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dermatology Lasers Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dermatology Lasers Market, by Product, 2024-2034
8.1.1. Solid-state Dermatology Lasers
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Gas Dermatology Lasers
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Pulsed Dye Dermatology Lasers
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Dermatology Lasers Market, by End User, 2024-2034
9.1.1. Hospital
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Ambulatory Surgical Centres
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Dermatology and Cosmetic Clinics.
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Dermatology Lasers Market, by Indication, 2024-2034
10.1.1. Hair Removal
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Facial Rejuvenation
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Tattoo Removal
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Scar Treatment
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Skin Cancer
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Psoriasis
10.1.6.1. Market Revenue and Forecast (2021-2034)
10.1.7. Vitiligo
10.1.7.1. Market Revenue and Forecast (2021-2034)
10.1.8. Varicose Veins
10.1.8.1. Market Revenue and Forecast (2021-2034)
10.1.9. Actinic Keratosis
10.1.9.1. Market Revenue and Forecast (2021-2034)
10.1.10. Wound Treatment
10.1.10.1. Market Revenue and Forecast (2021-2034)
11.1. Dermatology Lasers Market, by Technology, 2024-2034
11.1.1. Ablative Dermatology Lasers
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Non-ablative Dermatology Lasers
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. Dermatology Lasers Market, by Application, 2024-2034
12.1.1. Therapeutic
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Aesthetic
12.1.2.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.2. Market Revenue and Forecast, by End User (2021-2034)
13.1.3. Market Revenue and Forecast, by Indication (2021-2034)
13.1.4. Market Revenue and Forecast, by Technology (2021-2034)
13.1.5. Market Revenue and Forecast, by Application (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.6.2. Market Revenue and Forecast, by End User (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Indication (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Technology (2021-2034)
13.1.6.5. Market Revenue and Forecast, by Application (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.7.2. Market Revenue and Forecast, by End User (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Indication (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Technology (2021-2034)
13.1.7.5. Market Revenue and Forecast, by Application (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.2. Market Revenue and Forecast, by End User (2021-2034)
13.2.3. Market Revenue and Forecast, by Indication (2021-2034)
13.2.4. Market Revenue and Forecast, by Technology (2021-2034)
13.2.5. Market Revenue and Forecast, by Application (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.6.2. Market Revenue and Forecast, by End User (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Indication (2021-2034)
13.2.7. Market Revenue and Forecast, by Technology (2021-2034)
13.2.8. Market Revenue and Forecast, by Application (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.9.2. Market Revenue and Forecast, by End User (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Indication (2021-2034)
13.2.10. Market Revenue and Forecast, by Technology (2021-2034)
13.2.11. Market Revenue and Forecast, by Application (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.12.2. Market Revenue and Forecast, by End User (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Indication (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Technology (2021-2034)
13.2.13. Market Revenue and Forecast, by Application (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.14.2. Market Revenue and Forecast, by End User (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Indication (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Technology (2021-2034)
13.2.15. Market Revenue and Forecast, by Application (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.2. Market Revenue and Forecast, by End User (2021-2034)
13.3.3. Market Revenue and Forecast, by Indication (2021-2034)
13.3.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.5. Market Revenue and Forecast, by Application (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.6.2. Market Revenue and Forecast, by End User (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Indication (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.7. Market Revenue and Forecast, by Application (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.8.2. Market Revenue and Forecast, by End User (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Indication (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.9. Market Revenue and Forecast, by Application (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.2. Market Revenue and Forecast, by End User (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Indication (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.10.5. Market Revenue and Forecast, by Application (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.2. Market Revenue and Forecast, by End User (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Indication (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.11.5. Market Revenue and Forecast, by Application (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.2. Market Revenue and Forecast, by End User (2021-2034)
13.4.3. Market Revenue and Forecast, by Indication (2021-2034)
13.4.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.5. Market Revenue and Forecast, by Application (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.6.2. Market Revenue and Forecast, by End User (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Indication (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.7. Market Revenue and Forecast, by Application (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.8.2. Market Revenue and Forecast, by End User (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Indication (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.9. Market Revenue and Forecast, by Application (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.2. Market Revenue and Forecast, by End User (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Indication (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.10.5. Market Revenue and Forecast, by Application (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.2. Market Revenue and Forecast, by End User (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Indication (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.11.5. Market Revenue and Forecast, by Application (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.2. Market Revenue and Forecast, by End User (2021-2034)
13.5.3. Market Revenue and Forecast, by Indication (2021-2034)
13.5.4. Market Revenue and Forecast, by Technology (2021-2034)
13.5.5. Market Revenue and Forecast, by Application (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.6.2. Market Revenue and Forecast, by End User (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Indication (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Technology (2021-2034)
13.5.7. Market Revenue and Forecast, by Application (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.2. Market Revenue and Forecast, by End User (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Indication (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Technology (2021-2034)
13.5.8.5. Market Revenue and Forecast, by Application (2021-2034)
14.1. Cutera
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Cynosure
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. IPG Photonics Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. biolitec AG
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Alma Lasers
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbott
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Boston Scientific Corporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Quanta System.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Koninklijke Philips N.V.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Spectranetics
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample